Glioblastoma Multiforme
Showing NaN - NaN of 20
Glioblastoma Multiforme Trial in Australia, United States (Nativis Voyager RFE Therapy)
Completed
- Glioblastoma Multiforme
- Nativis Voyager RFE Therapy
-
Birmingham, Alabama
- +12 more
Jan 31, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)
Not yet recruiting
- Neoplasms
- +7 more
- Biological G207
-
Birmingham, AlabamaChildren's of Alabama
Jun 1, 2022
Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)
Active, not recruiting
- Glioblastoma Multiforme
- +6 more
- Dendritic cell immunotherapy
-
Birmingham, Alabama
- +85 more
May 12, 2022
Glioblastoma Multiforme Trial in Worldwide (drug, other, radiation)
Terminated
- Glioblastoma Multiforme
- Steroid eye drops
- +6 more
-
Los Angeles, California
- +21 more
Mar 19, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma, Mixed Trial in United States (Interferon-beta)
Completed
- Glioblastoma Multiforme
- +3 more
- Interferon-beta
-
Birmingham, Alabama
- +4 more
Nov 13, 2020
Glioblastoma Multiforme Trial in United States (poly ICLC, temozolomide, radiation therapy)
Completed
- Glioblastoma Multiforme
- poly ICLC
- +2 more
-
Birmingham, Alabama
- +8 more
May 30, 2019
Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)
Completed
- Glioblastoma Multiforme
- Cilengitide 500 mg
- Cilengitide 2000 mg
-
Birmingham, Alabama
- +16 more
Jan 18, 2019
Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)
Suspended
- Glioblastoma Multiforme
- ICT-107
- Placebo
-
Birmingham, Alabama
- +64 more
Aug 9, 2018
Glioblastoma Multiforme Trial in United States (ICT-121 DC vaccine)
Completed
- Glioblastoma Multiforme
- ICT-121 DC vaccine
-
Birmingham, Alabama
- +5 more
Aug 9, 2018
Adult Brain Glioblastoma, Glioblastoma Multiforme Trial in United States (SL-701; poly-ICLC (polyinosinic-polycytidylic acid
Completed
- Adult Brain Glioblastoma
- Glioblastoma Multiforme
- SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)
- Bevacizumab
-
Birmingham, Alabama
- +15 more
Jan 24, 2018
Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)
Completed
- Glioblastoma Multiforme
- NovoTTF-100A device
- Temozolomide
-
Birmingham, Alabama
- +88 more
Apr 7, 2017
Mixed Gliomas, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (XL765 (SAR245409), Temozolomide)
Completed
- Mixed Gliomas
- +2 more
- XL765 (SAR245409)
- Temozolomide
-
Birmingham, Alabama
- +5 more
Apr 9, 2013
Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131-I-TM-601, 131I-TM601)
Unknown status
- Malignant Glioma
- +5 more
-
Birmingham, Alabama
- +18 more
Apr 1, 2009